{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T06:09:10Z","timestamp":1762927750719},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1007\/s10620-005-3055-1","type":"journal-article","created":{"date-parts":[[2006,1,13]],"date-time":"2006-01-13T04:39:23Z","timestamp":1137127163000},"page":"2323-2329","source":"Crossref","is-referenced-by-count":24,"title":["Efficacy of Rebamipide Enemas in Active Distal Ulcerative Colitis and Proctitis: A Prospective Study Report"],"prefix":"10.1007","volume":"50","author":[{"given":"K.","family":"Makiyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Takeshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Hamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"3055_CR1","first-page":"15","volume-title":"Inflammatory Bowel Disease","year":"1998","unstructured":"Allison MC, Dhillon AP, Lewis WG, Pounder RE (eds): Inflammatory Bowel Disease. London, Mosby, 1998, pp 15\u201395"},{"key":"3055_CR2","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/00004836-198808000-00003","volume":"10","author":"RR Babb","year":"1988","unstructured":"Babb RR: Corticosteroids in ulcerative colitis: A skeptical view. J Clin Gastroenterol 10:365\u2013367, 1988","journal-title":"J Clin Gastroenterol"},{"key":"3055_CR3","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/00054725-200002000-00009","volume":"6","author":"DH Present","year":"2000","unstructured":"Present DH: How to do without steroids in inflammatory bowel disease. Inflamm Bowel Dis 6:48\u201357, 2000","journal-title":"Inflamm Bowel Dis"},{"key":"3055_CR4","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1053\/jcgh.2003.50005","volume":"1","author":"H Hanai","year":"2003","unstructured":"Hanai H, Watanabe F, Takeuchi K, Saniabadi A, Bjarnason I: Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: a prospective, uncontrolled study. Clin Gastroenterol Hepatol 1:28\u201335, 2003","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3055_CR5","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1053\/gast.2001.22122","volume":"120","author":"F Shanahan","year":"2001","unstructured":"Shanahan F: Inflammatory bowel disease: Immunodiagnostics, immunotherapeutics, and ecotherapeutics. Gastroenterology 120:622\u2013635, 2001","journal-title":"Gastroenterology"},{"key":"3055_CR6","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1365-2036.2004.02189.x","volume":"20","author":"T Yamamoto","year":"2004","unstructured":"Yamamoto T, Umegae S, Kitagawa T, Yasuda Y, Yamada Y, Takahashi D, Mukumoto M, Nishimura N, Yasue K, Matsijimoto K: Granulocyte and monocyte adsorptive apheresis in the treatment of active distal ulcerative colitis: a prospective, pilot study. Aliment Pharmacol Ther 20:783\u2013792, 2004","journal-title":"Aliment Pharmacol Ther"},{"key":"3055_CR7","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1136\/bmj.2.5104.1072","volume":"2","author":"SC Treulove","year":"1958","unstructured":"Treulove SC: Treatment of ulcerative colitis with local hydrocortisone hemisuccinate sodium: a report on a controlled therapeutic trial. Br Med J 2:1072\u20131077, 1958","journal-title":"Br Med J"},{"key":"3055_CR8","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1136\/gut.32.8.929","volume":"32","author":"M Campieri","year":"1991","unstructured":"Campieri M, Gionchetti P, Belluzzi A, Brignola C, Tampieri M, Iannone P, Miglioli M, Barbara L: Optimum dosage of 5-aminosalicylic acid as rectal enemas in patients with active ulcerative colitis. Gut 32:929\u2013931, 1991","journal-title":"Gut"},{"key":"3055_CR9","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/0016-5085(87)90621-4","volume":"92","author":"LR Sutherland","year":"1987","unstructured":"Sutherland LR, Martin F, Greer S, Robinson M, Greenberger N, Saibil F, Martin T, Sparr J, Prokipchuk ED, Borgen L: 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. Gastroenterology 92:1894\u20131898, 1987","journal-title":"Gastroenterology"},{"key":"3055_CR10","first-page":"736","volume":"90","author":"Bianchi Porro G","year":"1995","unstructured":"Bianchi Porro G, Ardizzone S, Petrillo M, Fasoli A, Molteni P, Imbesi V: Low Pentasa dosage versus hydrocortisone in the topical treatment of active ulcerative colitis: A randomized, double-blind study. Am J Gastroenterol 90:736\u2013739, 1995","journal-title":"Am J Gastroenterol"},{"key":"3055_CR11","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/00054725-199805000-00001","volume":"4","author":"Hanauer SB","year":"1998","unstructured":"Hanauer SB (for the U.S. PENTASA Enema Study Group): Dose-ranging study of mesalamine (PENTASA) enemas in the treatment of acute ulcerative proctosigmoiditis: Results of multicentered placebo-controlled trial. Inflamm Bowel Dis 4:79\u201383, 1998","journal-title":"Inflamm Bowel Dis"},{"key":"3055_CR12","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1159\/000199038","volume":"29","author":"WS Selby","year":"1984","unstructured":"Selby WS, Bennett MK, Jewell DP: Topical treatment of distal ulcerative colitis with 4-amino-salicylic acid enemas. Digestion 29:231\u2013234, 1984","journal-title":"Digestion"},{"key":"3055_CR13","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1365-2036.1990.tb00480.x","volume":"4","author":"SD Ryder","year":"1990","unstructured":"Ryder SD, Walker RJ, Jones H, Rhodes JM: Rectal bismuth subsalicylate as therapy for ulcerative colitis. Aliment Pharmacol Ther 4:333\u2013338, 1990","journal-title":"Aliment Pharmacol Ther"},{"key":"3055_CR14","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1136\/gut.34.5.676","volume":"34","author":"RD Pullan","year":"1993","unstructured":"Pullan RD, Ganesh S, Mani V, Morris J, Evans BK, Williams GT, Rhodes J: Comparison of bismuth citrate and 5-aminosalicylic acid enemas in distal ulcerative colitis: a controlled trial. Gut 34:676\u2013679, 1993","journal-title":"Gut"},{"key":"3055_CR15","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.3109\/00365528909089256","volume":"24","author":"S Bjorck","year":"1989","unstructured":"Bjorck S, Dahlstrom A, Ahlman H: Topical treatment of ulcerative colitis with lidocaine. Scand J Gastroenterol 24:1061\u20131072, 1989","journal-title":"Scand J Gastroenterol"},{"key":"3055_CR16","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/0016-5085(94)90394-8","volume":"106","author":"WJ Sandborn","year":"1994","unstructured":"Sandborn WJ, Tremaine WJ, Schroeder KW, Batts KP, Lawson GM, Steiner BL, Harrison JM, Zinsmeister AR: A placebo-controlled trial of cyclosporine enemas for mildly to moderately active left-sided ulcerative colitis. Gastroenterology 106:1429\u20131435, 1994","journal-title":"Gastroenterology"},{"key":"3055_CR17","doi-asserted-by":"crossref","first-page":"985","DOI":"10.3109\/00365529609003118","volume":"31","author":"WL Zea-Iriarte","year":"1996","unstructured":"Zea-Iriarte WL, Makiyama K, Goto S, Murase K, Urata Y, Sekine I, Hara K, Kondo T: Impairment of antioxidants in colonic epithelial cells isolated from trinitrobenzene sulphonic acid-induced colitis rats. Scand J Gastroenterol 31:985\u2013992, 1996","journal-title":"Scand J Gastroenterol"},{"key":"3055_CR18","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1046\/j.1365-2036.18.s1.5.x","volume":"18","author":"RM Genta","year":"2003","unstructured":"Genta RM: The role of rebamipide in the management of inflammatory disease of the gastrointestinal tract. Aliment Pharmacol Ther 18 (Suppl 1):8\u201313, 2003","journal-title":"Aliment Pharmacol Ther"},{"key":"3055_CR19","first-page":"5S","volume":"43","author":"T Arakawa","year":"1998","unstructured":"Arakawa T, Kobayashi K, Yoshikawa T, Tarnawski A: Rebamipide: overview of its mechanisms of action and efficacy in mucosal protection and ulcer healing. Dig Dis Sci 43 (Suppl 9):5S\u201313S, 1998","journal-title":"Dig Dis Sci"},{"key":"3055_CR20","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1111\/j.1572-0241.2000.02154.x","volume":"95","author":"K Makiyama","year":"2000","unstructured":"Makiyama K, Takeshima F, Kawasaki H, Zea-Iriarte WL: Anti-inflammatory effect of rebamipide enema on proctitis type ulcerative colitis: A novel therapeutic alternative. Am J Gastroenterol 95:1838\u20131839, 2000","journal-title":"Am J Gastroenterol"},{"key":"3055_CR21","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00054725-200108000-00009","volume":"7","author":"PG Farup","year":"2001","unstructured":"Farup PG, Hinterleitner TA, Lukas M, Hebuterne X, Rachmilewitz D, Campieri M, Meier R, Keller R, Rathbone B, Oddsson E: Mesalazine 4 g daily given as prolonged-release granules twice daily and four times daily is at least as effective as prolonged-release tablets four times daily in patients with ulcerative colitis. Inflamm Bowel Dis 7:237\u2013242, 2001","journal-title":"Inflamm Bowel Dis"},{"key":"3055_CR22","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/bmj.298.6666.82","volume":"298","author":"D Rachmilewitz","year":"1989","unstructured":"Rachmilewitz D on behalf of an international study group: Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomized trial. Br Med J 298:82\u201386, 1989","journal-title":"Br Med J"},{"key":"3055_CR23","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3109\/00365528708991491","volume":"22","author":"C-H Floren","year":"1987","unstructured":"Floren C-H, Benoni C, Willen R: Histologic and colonoscopic assessment of disease extension in ulcerative colitis. Scand J Gastroenterol 22:459\u2013462, 1987","journal-title":"Scand J Gastroenterol"},{"key":"3055_CR24","first-page":"393","volume":"120","author":"SGF Matts","year":"1961","unstructured":"Matts SGF: The value of rectal biopsy in the diagnosis of ulcerative colitis. Q J Med, New Ser XXX 120:393\u2013407, 1961","journal-title":"Q J Med, New Ser XXX"},{"key":"3055_CR25","first-page":"81","volume":"3","author":"SB Hanauer","year":"2003","unstructured":"Hanauer SB, Present DH: The state of the art in the management of inflammatory bowel disease. Rev Gastroenterol Disord 3:81\u201392, 2003","journal-title":"Rev Gastroenterol Disord"},{"key":"3055_CR26","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/00004836-199506000-00004","volume":"20","author":"A Kornbluth","year":"1995","unstructured":"Kornbluth A, Marion JF, Salomon P, Janowitz HD: How effective is current medical therapy for severe ulcerative colitis and Crohn's colitis? An analytic review of selected trials. J Clin Gastroenterol 20:280\u2013284, 1995","journal-title":"J Clin Gastroenterol"},{"key":"3055_CR27","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0140-6736(77)90831-5","volume":"2","author":"AK Azad Khan","year":"1977","unstructured":"Azad Khan AK, Piris J, Truelove SC: An experiment to determine the active therapeutic moiety of sulphasalazine. Lancet 2:892\u2013895, 1977","journal-title":"Lancet"},{"key":"3055_CR28","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1007\/BF01308601","volume":"38","author":"A Kleine","year":"1993","unstructured":"Kleine A, Kluge S, Peskar BM: Stimulation of prostaglandin biosynthesis mediates gastroprotective effect of rebamipide in rats. Dig Dis Sci 38:1441\u20131449, 1993","journal-title":"Dig Dis Sci"},{"key":"3055_CR29","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1007\/BF02063257","volume":"40","author":"T Arakawa","year":"1995","unstructured":"Arakawa T, Watanabe T, Fukuda T, Yamasaki K, Kobayashi K: Rebamipide, novel prostaglandin-inducer accelerates healing and reduces relapse of acetic acid-induced rat gastric ulcer: Comparison with cimetidine. Dig Dis Sci 40:2469\u20132472, 1995","journal-title":"Dig Dis Sci"},{"key":"3055_CR30","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1046\/j.1365-2036.18.s1.13.x","volume":"18","author":"H Bamba","year":"2003","unstructured":"Bamba H, Ota S, Kato A, Miyatani H, Kawamoto C, Yoshida Y, Fujiwara K: Effect of rebamipide on prostaglandin receptors\u2013mediated increase of inflammatory cytokine production by macrophages. Aliment Pharmacol Ther 18 (Suppl 1):113\u2013118, 2003","journal-title":"Aliment Pharmacol Ther"},{"key":"3055_CR31","doi-asserted-by":"crossref","first-page":"90S","DOI":"10.1023\/A:1018828105226","volume":"43","author":"A Tarnawski","year":"1998","unstructured":"Tarnawski A, Arakawa T, Kobayashi K: Rebamipide treatment activates epidermal growth factor and its receptor expression in normal and ulcerated gastric mucosa in rats. One mechanism for its ulcer healing action? Dig Dis Sci 43:90S\u201398S, 1998","journal-title":"Dig Dis Sci"},{"key":"3055_CR32","first-page":"160S","volume":"43","author":"M Aihara","year":"1998","unstructured":"Aihara M, Imagawa K, Funakoshi Y, Ohmoto Y, Kikuchi M: Effects of rebamipide on production of several cytokines by human peripheral blood mononuclear cells. Dig Dis Sci 43 (Suppl 9):160S\u2013166S, 1998","journal-title":"Dig Dis Sci"},{"key":"3055_CR33","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1159\/000073645","volume":"20","author":"S Shimada","year":"2003","unstructured":"Shimada S, Inoue K, Kuramoto M, Suzuki S, Yamamoto K, Ogawa M: Preoperative administration of rebamipide significantly lowers body temperature and circulating interleukin-6 in gastric cancer patients after gastrectomy. Dig Surg 20:500\u2013505, 2003","journal-title":"Dig Surg"},{"key":"3055_CR34","first-page":"174S","volume":"43","author":"M Aihara","year":"1998","unstructured":"Aihara M, Azuma A, Takizawa H, Tsuchimoto D, Funakoshi Y, Shindo Y, Ohmoto Y, Imagawa K, Kikuchi M, Mukaida N, Matsushima K: Molecular analysis of suppression of interleukin-8 production by rebamipide in Helicobacter pylori-stimulated gastric cancer cell lines. Dig Dis Sci 43 (Suppl 9):174S\u2013180S, 1998","journal-title":"Dig Dis Sci"},{"key":"3055_CR35","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1136\/gut.40.6.775","volume":"40","author":"JK Marshall","year":"1997","unstructured":"Marshall JK, Irvine EJ: Rectal corticosteroids versus alternative treatments in ulcerative colitis: a meta-analysis. Gut 40:775\u2013781, 1997","journal-title":"Gut"},{"key":"3055_CR36","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/j.1572-0241.2000.01940.x","volume":"95","author":"RD Cohen","year":"2000","unstructured":"Cohen RD, Woseth DM, Thisted RA, Hanauer SB: A meta-analysis and overview of the literature on treatment options for left-sided ulcerative colitis and ulcerative proctitis. Am J Gastroenterol 95:1263\u20131276, 2000","journal-title":"Am J Gastroenterol"},{"key":"3055_CR37","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1056\/NEJMoa013136","volume":"349","author":"A Sinha","year":"2003","unstructured":"Sinha A, Nightingale JMD, West KP, Berlanga-Acosta J, Playford RJ: Epidermal growth factor enemas with oral mesalamine for mild-to-moderate left-sided ulcerative colitis or proctitis. N Engl J Med 349:350\u2013357, 2003","journal-title":"N Engl J Med"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-005-3055-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-005-3055-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-005-3055-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T15:35:40Z","timestamp":1559230540000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-005-3055-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":37,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["3055"],"URL":"https:\/\/doi.org\/10.1007\/s10620-005-3055-1","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}